Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
21 - 30 out of 68Page size: 10
  1. 2022
  2. Published

    Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial

    Waijer, S. W., Vart, P., Cherney, D. Z. I., Chertow, G. M., Jongs, N., Langkilde, A. M., Mann, J. F. E., Mosenzon, O., McMurray, J. J. V., Rossing, Peter, Correa-Rotter, R., Stefansson, B. V., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2022, In: Diabetologia. 65, 7, p. 1085-1097 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial

    Ersbøll, M., Jürgens, M., Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Brandt-Jacobsen, N. H., Gæde, P., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn, Schou, Morten & Kistorp, Caroline Michaela Nervil, 2022, In: International Journal of Cardiovascular Imaging. 38, p. 579–587

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER

    Shaman, A. M., Bain, S. C., Bakris, G. L., Buse, J. B., Idorn, T., Mahaffey, K. W., Mann, J. F. E., Nauck, M. A., Rasmussen, S., Rossing, Peter, Wolthers, B., Zinman, B. & Perkovic, V., 2022, In: Circulation. 145, 8, p. 575-585 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

    Tougaard, N. H., Frimodt-Møller, M., Salmenkari, H., Stougaard, E. B., Zawadzki, A. D., Mattila, I. M., Hansen, T. W., Legido-Quigley, C., Hörkkö, S., Forsblom, C., Groop, P. H., Lehto, M. & Rossing, Peter, 2022, In: Journal of Clinical Medicine. 11, 13, 3573.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Effects of Dapagliflozin in People without Diabetes and with Microalbuminuria

    Heerspink, H. J. L., Chertow, G. M., Jongs, N., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Langkilde, A. M. & Wheeler, D. C., 2022, In: Clinical Journal of the American Society of Nephrology. 17, 11, p. 1665-1668 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  7. Published

    Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results

    Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Ruilope, L. M., Boletis, J., Toto, R., Umpierrez, G. E., Wanner, C., Wada, T., Scott, C., Joseph, A., Ogbaa, I., Roberts, L., Scheerer, M. F., Bakris, G. L. & FIDELIO-DKD Investigators, F. I., 2022, In: Nephrology Dialysis Transplantation. p. 1261–1269 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions

    Vart, P., Correa-Rotter, R., Hou, F. F., Jongs, N., Chertow, G. M., Langkilde, A. M., McMurray, J. J. V., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Douthat, W., Escudero, E., Isidto, R., Khullar, D., Bajaj, H. S., Wheeler, D. C. & Heerspink, H. J. L., 2022, In: Kidney International Reports. 7, 4, p. 699-707 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trial

    Rossing, Peter, Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Amod, A., Marre, M., Joseph, A., Lage, A., Scott, C., Bakris, G. L. & the FIDELIO-DKD Investigators, T. F. I., 2022, In: Diabetes, Obesity and Metabolism. 24, 1, p. 125-134 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence

    Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., Sadusky, T., Tandon, N., Tuttle, K. R., Wanner, C., Wilkens, K. G., Zoungas, S., Craig, J. C., Tunnicliffe, D. J., Tonelli, M. A., Cheung, M. & 2 others, Earley, A. & de Boer, I. H., 2022, In: Kidney International. 102, 5, p. 990-999 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial

    FIGARO DKD Investigators, F. D. I., 2022, In: Circulation. 145, 6, p. 437-447 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 Next

ID: 12937790